Massachusetts cannabis audit finds 13% of flower products have inaccurate THC labels

An audit conducted by the Massachusetts Cannabis Control Commission (CCC) revealed that 13% of tested cannabis flower products fell outside the acceptable range of THC variation allowed on labels. The audit, which examined 63 flower products from 62 producers, established that an accurate label must fall within 75% to 125% of the potency shown.

Of the samples tested, only seven products were within 2% of their labeled potency. The 13 noncompliant products have been placed on administrative holds. Producers of these products must now take corrective actions, which include recalling and repurposing the items with new testing, recalling and relabeling them with audit results, retesting, or destroying the product.

CCC Executive Director Travis Ahern stated the audit is part of an internal testing task force mission to oversee a safe marketplace. CCC Chair Chris Harding emphasized that accurate labeling is a matter of health and safety, particularly for medical patients who depend on precise potency for dosing.